For chronic-degenerative, oncological, immunological, cardiovascular-dysmetabolic and infectious diseases, innovative drugs are being developed that can respond to the needs of patients and that have helped to cure diseases for which, until a few years ago, there were no therapeutic prospects. The world of drugs is, therefore, changing rapidly and the Pharmacologist must be updated in real time in terms of training, appropriateness and preclinical, translational and clinical research.

In the annual Congress, highly topical issues were addressed with the aim of implementing a multidisciplinary dialogue through joint symposia with the specific clinical societies of the various therapeutic areas, also stimulating the participation of specialist doctors.

They discussed with various stakeholders in the drug development chain about "The scientific value and appropriate use of the drug", t. Basic and clinical pharmacologists must be the main actors (SIF-First) who will have to promote post-congress activities and initiatives with other public and private research experts, with regulators and politicians, with citizen-patient associations and with pharmaceutical companies with constructive comparison methods.

40° Congresso Nazionale della Società Italiana di Farmacologia (SIF)